Amarantus BioScience Holdings, Inc. (AMBS)

Market Cap	630.00
Revenue (ttm)	n/a
Net Income (ttm)	-7.94M
Shares Out	630.41M
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	216,868
Open	n/a
Previous Close	n/a
Day's Range	n/a
52-Week Range	n/a
Beta	-42.31
RSI	47.32
Earnings Date	n/a

About AMBS

Amarantus BioScience Holdings, Inc., a biopharmaceutical company, focuses on the development of diagnostic and therapeutic product candidates in the areas of neurology, psychiatry, ophthalmology, and regenerative medicine. The company’s diagnostic products in development include the lymphocyte proliferation (LymPro) test, a diagnostic blood test for Alzheimer’s disease; and MSPrecise, a proprietary DNA sequencing assay for the identification of patients with multiple sclerosis. Its therapeutic products in development comprise Eltoprazine, a sma...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 12
• Stock Exchange: OTCMKTS
• Ticker Symbol: AMBS